Table 1.
X-ray crystallography | Nuclear magnetic resonance |
---|---|
• Crystalline state, however, the crystals contain ~30–70% of disordered solvent | • Solution conditions (requires weeks of stability for data collection). |
• Theoretically no structure size limit • Proteins purified from natural sources can be used |
• High resolution structures up to ~30 kDa. |
• Expression with isotope is typically not required for proteins or DNA. Sometimes selenomethionine is incorporated instead of Met. | • Protein/DNA samples usually require 13C and 15N labeling (stable isotopes). Cost of expression is prohibitive except in prokaryotes. |
• X-rays diffraction data are recorded, and the diffraction patterns are used to calculate initial electron density maps. The maps are used to trace a model of the macromolecule, that is later refined and validated | • Data is nuclear resonance frequencies of primarily 1H, 13C, and 15N. Distances between 1H atoms are used to build ensembles of possible structures. |
• Highly flexible/disordered regions of proteins cannot be modeled and are absent in the final models | • Motion and disorder can be directly measured on many time scales. |
Mass spectrometry | Cryo-electron microscopy |
• Typically used in protection assays for epitope mapping. • High sensitivity/low sample requirements. • Atomic resolution identifies specific residues for protection from modification. • Residues that are convenient to modify in protection assays are not always useful for epitope mapping. • Chemistry of modification procedures can have off target effects. |
• Can determine atomic resolution structures frozen from solution in vitreous ice. • Low sample requirements. • Resolution occasionally as good as X-ray crystallography. • Performs better on very large samples with high symmetry, typically 100's of kDa, so it is currently not easily or generally applicable to allergen epitope mapping. |